Article
The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Oct 2016
Gao Tianyi, Mei Yanping, Sun Huiling, Nie Zhenlin, Liu Xiangxiang, Wang Shukui
Abstract excerpt
OBJECTIVE: Phosphatase and tensin homolog (PTEN) deleted on chromosome 10, a tumor suppressor that negatively regulates the phosphoinositide-3-kinase(PI3K) which has been implicated in a number of human malignancies including prostate cancer. However the prognostic value of PTEN deletion in prostate cancer patient's diagnosis and the mechanism of PTEN deletion in prostate cancer development still remain unclear....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
